XPONANCE LLC

Position in NVAX — Novavax Inc

CIK 1637541 PHILADELPHIA, PA

Position in NVAX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$137,174

+$25,176 QoQ

Shares Held

14,562

+5.8% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#152

of 263 holders

Holding Since

Jun 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XPONANCE LLC holds $117,820,260 across 121 Biotechnology names. NVAX ranks #89 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,980	$22,839,645
2	REGN	Regeneron Pharmaceuticals, Inc.	18,063	$11,263,003
3	ALNY	Alnylam Pharmaceuticals, Inc.	30,242	$9,103,749
4	RVMD	Revolution Medicines, Inc.	40,460	$7,577,348
5	INSM	INSMED Inc	48,273	$5,146,867
6	INCY	Incyte Corp	29,027	$3,290,500
7	RPRX	Royalty Pharma plc	55,752	$3,126,014
8	MRNA	Moderna, Inc.	39,368	$2,756,941

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$137,174	14,562	+5.8%	Shares	Sole	2026-08-10
2026-03-31	$111,998	13,759	+16.7%	Shares	Sole	2026-05-13
2025-12-31	$79,235	11,791	+1.1%	Shares	Sole	2026-02-12
2025-09-30	$101,066	11,657	+0.5%	Shares	Sole	2025-11-12
2025-06-30	$73,073	11,599	-1.4%	Shares	Sole	2025-08-14
2025-03-31	$75,375	11,759	-0.6%	Shares	Sole	2025-05-01
2024-12-31	$95,121	11,831	-5.0%	Shares	Sole	2025-02-11
2023-03-31	$86,333	12,458	+10.9%	Shares	Sole	2023-04-18
2022-12-31	$115,506	11,236	+21.9%	Shares	Sole	2023-01-24
2022-06-30	$474,081	9,218	+6.0%	Shares	Sole	2022-08-02
2022-03-31	$640,386	8,695	+1.1%	Shares	Sole	2022-04-20
2021-12-31	$1,230,402	8,600	+2.8%	Shares	Sole	2022-01-31
2021-09-30	$1,733,526	8,362	-3.7%	Shares	Sole	2021-11-05
2021-06-30	$1,844,336	8,687	+223.4%	Shares	Sole	2021-08-12
2020-06-30	$223,878	2,686	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.